Members meet with Congress this month to discuss access to rheumatology, access to treatments, and funding for research
ACR Winter Rheumatology Symposium: Tips for ANCA Testing
How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests
ACR Winter Rheumatology Symposium: The Search for Answers in Sjögren’s Syndrome
Research has led to greater understanding of the disease, potential for better treatment options
ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy
Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging
ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise
Toxicity and appropriate targeting are challenges for small molecule researchers
Legal Updates: What Rheumatologists Should Consider Before Signing with an ACO
Medicare’s ACO physician exclusivity provisions may preclude participation in more than one accountable care organization
Large Genome Study Identifies Genetic Risk Factors for Gout
Researchers have identified 28 genome-wide significant urate concentration–associated loci, underscoring the importance of metabolic control in urate production.
Sequester Affects Rheumatologists on Two Fronts—Medicare Reimbursement and Research Funding
Rheumatologists are already feeling two effects from Congress’ inability to solve sequestration: a 2% reduction in Medicare reimbursements and slashed funding for research financed by the National Institutes of Health.
DNA Methylation Modifies Genetic Risk for Rheumatoid Arthritis
A first-of-its-kind study has been published that integrates genotype and epigenotype data across the entire genome.
President’s Perspective: ACR Calls on Members to Advance Rheumatology
Members’ support and participation is needed to strengthen the ACR’s lobbying efforts with Congress
- « Previous Page
- 1
- …
- 237
- 238
- 239
- 240
- 241
- …
- 303
- Next Page »